Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eyenovia Inc (EYEN)  
$0.71 0.08 (13.37%) as of 4:30 Mon 4/29


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,880,000
Market Cap: 17.72(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5165 - $5.75
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eyenovia is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its microdose array print (MAP™) platform technology, branded the Optejet®. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens that causes the gradual loss of the eye's ability to focus on near objects and impairs near visual acuity. Mydcombi™ is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 160,717 165,607 357,711 654,329
Total Buy Value $176,411 $183,061 $635,654 $1,182,496
Total People Bought 1 2 6 7
Total Buy Transactions 3 4 15 28
Total Shares Sold 0 0 94,000 234,000
Total Sell Value $0 $0 $508,560 $1,148,560
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 5
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 54
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Grant Stuart M.   –       –       •   2021-08-17 4 B $4.00 $93,676 D/D 23,419 4,338,859 0.01 -4%     
   Clasby Jennifer G VP, Regulatory and Clinical   •       –      –    2021-06-17 4/A D $5.42 $74,119 D/D (13,675) 66,537     -
   Clasby Jennifer G VP, Regulatory and Clinical   •       –      –    2021-06-17 4 D $5.42 $77,300 D/D (14,262) 65,950     -
   Clasby Jennifer G VP, Regulatory and Clinical   •       –      –    2021-06-17 4 OE $1.95 $47,795 D/D 24,510 80,212     -
   Lee Kenneth B Jr Director   –       •      –    2021-06-15 4 B $5.41 $10,812 D/D 2,000 25,359 2.39 12%     
   Lee Kenneth B Jr Director   –       •      –    2021-06-14 4 B $5.47 $10,940 D/D 2,000 23,359 2.39 6%     
   Lee Kenneth B Jr Director   –       •      –    2021-06-11 4 B $5.38 $10,760 D/D 2,000 21,359 2.39 5%     
   Mather Charles E Iv Director   –       •      –    2021-05-28 4 B $4.76 $14,268 D/D 3,000 26,359 2.39 24%     
   Rowe Michael M Chief Operating Officer   •       –      –    2021-05-27 4 B $4.71 $6,594 D/D 1,400 2,800 2.74 19%     
   Grant Stuart M.   –       –       •   2021-04-20 4 B $4.70 $143,500 D/D 30,000 4,315,440 0.01 7%     
   Grant Stuart M.   –       –       •   2021-04-19 4 B $4.86 $150,163 D/D 30,692 4,285,440 0.01 -2%     
   Haller Julia A Director   –       •      –    2021-03-31 4 A $0.00 $0 D/D 1,223 1,223     -
   Grant Stuart M.   –       –       •   2021-03-05 4 B $5.50 $192,500 D/D 35,000 4,254,748 0.01 -17%     
   Mario Ernest Director   –       •      –    2021-01-15 4 OE $2.27 $93,560 D/D 41,216 375,743     -
   Ianchulev Tsontcho Chief Executive Officer   •       •      –    2021-01-05 4 OE $2.27 $93,560 D/D 41,216 549,895     -
   Labelle Curt H Director   –       •      –    2020-11-20 4 D $0.00 $0 I/I (453,333) 0     -
   Ianchulev Tsontcho Chief Executive Officer   •       •      –    2020-11-20 4 D $0.00 $0 I/I (453,333) 0     -
   Gandolfo John P Chief Financial Officer   •       –      –    2020-11-19 4 B $3.40 $13,600 D/D 4,000 6,000 2.74 51%     
   Grant Stuart M.   –       –       •   2020-10-12 4 B $3.50 $355,000 D/D 100,000 4,219,748 0.01 92%     
   Grant Stuart M.   –       –       •   2020-09-24 4 B $2.98 $224,500 D/D 75,000 4,119,748 0.01 119%     
   Clasby Jennifer G VP, Clinical Operations   •       –      –    2020-09-18 4 OE $1.95 $52,137 D/D 26,737 55,702     -
   Eshelman Fredric N Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 1,292,787     -
   Mather Charles E Iv Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 23,359     -
   Lee Kenneth B Jr Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 19,359     -
   Sun Anthony Y Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 19,359     -
  54 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us